# LIXTE BIOTECHNOLOGY HLDGS IN (LIXT)

> Institutional ownership reported to the SEC as of Q2 2023, from Form 13F filings. Source: https://holderbook.com/stocks/LIXT/

- Reporting holders: 1
- Reported value: $205.2K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Ethos Financial Group, LLC](https://holderbook.com/funds/1954242-ethos-financial-group-llc/) | $205.2K | 248,084 | 0.1% | 3 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2023 | 1 | $205.2K |
| Q1 2023 | 10 | $452.0K |
| Q4 2022 | 15 | $361.2K |
| Q3 2022 | 13 | $363.0K |
| Q2 2022 | 14 | $652.0K |
| Q1 2022 | 11 | $1.5M |
| Q4 2021 | 10 | $1.4M |
| Q3 2021 | 9 | $2.5M |
| Q2 2021 | 10 | $7.4M |
| Q1 2021 | 7 | $4.4M |
| Q4 2020 | 3 | $714.0K |